References
- de Jongste M IL, Oosterhuis H JGH, Lie K I. Intractable ventricular tachycardia in a patient with giant cell myocarditis, thymoma and myasthenia gravis. Int J Cardiol 1986; 13: 374–378
- Hol'stad H, Ohm O-J, Mork S J, Aarli J A. Heart disease in myasthenia gravis. Acta Neural Scand 1984; 70: 176–184
- Burke J S, Medline N M, Katz A. Giant cell myocarditis associated with thymoma and myasthenia gravis. Arch Pathol 1969; 88: 359–366
- Rowland L P, Hoefer P FA, Aranow H, Merrit H H. Fatalilies in myasthenia gravis. Neurology 1956; 6: 307–326
- Büyüküztürk K, Özdemir Z, Kohcn D. Electrocardiographic findings in 24 patients with myasthenia gravis. Acta Cardiol 1976; 4: 301–305
- Luomanmäki J, Hokkanen E, Heikkilä J. Electrocardiogram in myasthenia gravis. Analysis of a series of 97 patients. Ann Clin Res 1969; 1: 236–245
- Kohn P M, Tucker H J, Kozokoff N J. The cardiac manifestations of myasthenia gravis with particular reference to electrocardiographic abnormalities. Am J Med Sci 1965; 249: 561–569
- Rottino A, Poppiti R, Rao J. Myocardial lesions in myasthenia gravis: review and report of a case. Arch Pathol 1942; 34: 557–561
- Russel D S. Histological changes in the striped muscles in myaslhehia gravis. J Pathol Bacteriol 1953; 65: 279–289
- Mendelow H, Genkins G. Studies in myasthenia gravis: cardiac and associated pathology. J Mt Sinai Hosp 1954; 21: 218–225
- Genkins G, Mendelow H, Sobel H J, Ossermann K E. (1961) Myasthenia gravis. The 2nd International Symposium Proceedings. 1961. C.C. Thomas, Springfield, 519–530
- Huvos A G, Pruzanski W. Smooth muscle involvement in primary muscle disease. Arch Pathol 1967; 184: 280–285
- Strauss A JL, Kemp PG, jr. Serum autoantibodics in myasthenia gravis and thymoma: selective affinity for I-bands of striated muscle as a guide for identification of antigen(s). J Immunol 1967; 99: 945–953
- Mendell J R, Whitaker J N, Engel W K. The skeletal muscle binding site of antistriated muscle antibody in myasthenia gravis: an electronmicroscopic study using peroxide conjugated antibody fragments. J Immunol 1973; 111: 847–856
- Gilhus N E, Aarli J A, Matre R. Myasthenia gravis: antibodies to skeletal muscle surface antigens. J Neuroimmunol 1983; 5: 239–249
- Aarli J A, Stefansson K, Marton L SG, Wollmann R L. Patients with myasthenia gravis and thymoma have in their sera IgG antibodies against titin. Clin Exp Immunol 1990; 82: 284–288
- Lisak R P, Barchi R L. Myasthenia gravis. W.B. Saunders, Philadelphia 1982
- Compston D AS, Vincent A, Newsom-Davis J, Batchelor J R. Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis. Brain 1980; 103: 579–601
- Aarli J A, Lefvert A K, Tönder O. Thymoma-specific antibodies in sera from patients with myasthenia gravis demonstrated by indirect haemagglutination. J Neuroimmunol 1981; 1: 421–427
- Lefvert A K, Bergström K, Matell G, Osterman P O, Pirskanen R. Determination of acetylcholine receptor antibody in myasthenia gravis—clinical usefulness and pathogenetic implications. J Neurol Neurosurg Psychiat 1978; 41: 394–403
- Engvall E, Perlmann P. Enzyme-linked immunosorbent assay, ELISA. III. Quantitation of specific antibodies by enzymelabeled anti-immunoglobulin in antigen-coated tubes. J Immunol 1972; 109: 129–135
- Lindström J. An assay for antibodies to human acetylcholin receptor in serum from patients with myasthenia gravis. Clin Immunol Immunopathol 1977; 7: 36–43
- Beutner E H, Witebsk E, Djanian A Y. Serologic studies of myasthenia gravis. Ann NY Acad Sci 1965; 124: 709–729
- Mehl V S, Lang R W. Myasthenia gravis. Identification of skeletal and heart muscle antigens not related to acetylcholine receptor. J Neuroimmunol 1984; 6: 347–360
- Connor R I, Lefvert A-K, Benes S C, Lang R W. Incidence and reactivity patterns of skeletal and heart (SH) reactive autoantibodies in the sera of patients with myasthenia gravis. J Neuroimmunol 1990; 26: 147–157